Genomic biomarkers correlate with HLA-identical renal transplant tolerance

55Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

Abstract

The ability to achieve immunologic tolerance after transplantation is a therapeutic goal. Here, we report interim results from an ongoing trial of tolerance in HLAidentical sibling renal transplantation. The immunosuppressive regimen included alemtuzumab induction, donor hematopoietic stem cells, tacrolimus/mycophenolate immunosuppression converted to sirolimus, and complete drug withdrawal by 24 months post-transplantation. Recipients were considered tolerant if they had normal biopsies and renal function after an additional 12 months without immunosuppression. Of the 20 recipients enrolled, 10 had at least 36 months of follow-up after transplantation. Five of these 10 recipients had immunosuppression successfully withdrawn for 16-36 months (tolerant), 2 had disease recurrence, and 3 had subclinical rejection in protocol biopsies (nontolerant). Microchimerism disappeared after 1 year, and CD4+CD25highCD1272FOXP3+ regulatory T cells and CD19+IgD/M+CD272 B cells were increased through 5 years post-transplantation in both tolerant and nontolerant recipients. Immune/inflammatory gene expression pathways in the peripheral blood and urine, however, were differentially downregulated between tolerant and nontolerant recipients. In summary, interim results from this trial of tolerance in HLA-identical renal transplantation suggest that predictive genomic biomarkers, but not immunoregulatory phenotyping, may be able to discriminate tolerant from nontolerant patients. Copyright © 2013 by the American Society of Nephrology.

References Powered by Scopus

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells

945Citations
N/AReaders
Get full text

HLA-mismatched renal transplantation without maintenance immunosuppression

906Citations
N/AReaders
Get full text

Identification of a B cell signature associated with renal transplant tolerance in humans

597Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation

164Citations
N/AReaders
Get full text

Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients

79Citations
N/AReaders
Get full text

Immune Tolerance for Autoimmune Disease and Cell Transplantation

69Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Leventhal, J. R., Mathew, J. M., Salomon, D. R., Kurian, S. M., Suthanthiran, M., Tambur, A., … Miller, J. (2013). Genomic biomarkers correlate with HLA-identical renal transplant tolerance. Journal of the American Society of Nephrology, 24(9), 1376–1385. https://doi.org/10.1681/ASN.2013010068

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 13

42%

Researcher 10

32%

Professor / Associate Prof. 8

26%

Readers' Discipline

Tooltip

Medicine and Dentistry 18

60%

Immunology and Microbiology 5

17%

Agricultural and Biological Sciences 4

13%

Biochemistry, Genetics and Molecular Bi... 3

10%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 6

Save time finding and organizing research with Mendeley

Sign up for free